Elite rolls out generic Vyvanse
Generic Vyvanse is indicated for the treatment of attention deficit hyperactivity disorder.
Elite has launched Elite's a generic version of Vyvanse (lisdexamfetamine disylate) in dosage strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules.
Generic Vyvanse is indicated for the treatment of attention deficit hyperactivity disorder.
[Read more: Elite rolls out generic Tylenol with Codeine]
The product had a market value of roughly $4.3 billion for the 12 months ending October 2024, per IQVIA.